Cargando…
Successful treatment of allergic bronchopulmonary aspergillosis with posaconazole in a child with cystic fibrosis: Case report and review of the literature
Allergic bronchopulmonary aspergillosis (ABPA) is recognized as a rare, progressive, allergic disorder in patients with cystic fibrosis (CF) and asthma. Treatment of ABPA mainly includes systemic corticosteroids (CSs) and antifungal agents. Here, we report posaconazole treatment in a 9-year-old male...
Autores principales: | Yakut, Nurhayat, Kadayifci, Eda Kepenekli, Eralp, Ela Erdem, Gokdemir, Yasemin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer - Medknow
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7065555/ https://www.ncbi.nlm.nih.gov/pubmed/32108603 http://dx.doi.org/10.4103/lungindia.lungindia_288_19 |
Ejemplares similares
-
Allergic Bronchopulmonary Aspergillosis in Asthma and Cystic Fibrosis
por: Knutsen, Alan P., et al.
Publicado: (2011) -
Allergic bronchopulmonary aspergillosis in patients with cystic fibrosis
por: Janahi, Ibrahim Ahmed, et al.
Publicado: (2017) -
Omalizumab in allergic bronchopulmonary aspergillosis in patients with cystic fibrosis
por: Ashkenazi, Moshe, et al.
Publicado: (2018) -
Allergic bronchopulmonary aspergillosis in patients with cystic fibrosis and non-cystic fibrosis bronchiectasis
por: Alyasin, Soheila, et al.
Publicado: (2018) -
Omalizumab in allergic bronchopulmonary aspergillosis in patients with cystic fibrosis [Erratum]
Publicado: (2018)